Published in World J Gastroenterol on April 07, 2006
Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer. Cancer Immunol Immunother (2012) 1.27
Complete response to preoperative chemoradiotherapy in highly advanced gastric adenocarcinoma. World J Gastrointest Oncol (2010) 0.77
Long-term survival of resected advanced gastric cancer with hepatic and pancreatic invasion. Case Rep Gastroenterol (2011) 0.75
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med (2001) 18.77
Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer (1999) 8.61
Extended lymph-node dissection for gastric cancer. N Engl J Med (1999) 7.43
Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer (1999) 6.76
American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays. J Clin Oncol (2004) 4.48
Gastric cancer: a curable disease in Britain. BMJ (1993) 4.24
Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group. Oncology (2000) 3.50
EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA. Cancer Chemother Rep (1964) 2.55
Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol (2003) 2.27
Chemotherapy sensitivity and resistance assays: a systematic review. J Clin Oncol (2004) 2.09
Excisional surgery for cancer cure: therapy at a cost. Lancet Oncol (2003) 2.09
Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg (2002) 2.04
Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg (1999) 1.96
Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer (2003) 1.95
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol (2005) 1.93
Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer. J Clin Oncol (1999) 1.88
A pilot study of preoperative chemoradiotherapy for resectable gastric cancer. Ann Surg Oncol (2001) 1.85
Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer. J Clin Oncol (1999) 1.84
Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol (2002) 1.81
Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up. Br J Cancer (2001) 1.70
Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg (1999) 1.59
Optimal locoregional treatment in gastric cancer. J Clin Oncol (2005) 1.54
Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol (1998) 1.50
Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline. Can J Surg (2002) 1.47
Rseults of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence. World J Surg (1977) 1.43
Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma. Cancer (2001) 1.33
Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori (2002) 1.23
The National Cancer Data Base report on gastric carcinoma. Cancer (1997) 1.23
Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study. Ann Surg Oncol (1995) 1.23
A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer (1995) 1.22
Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group. Lancet (1999) 1.22
Prognostic significance of lymph node dissection in gastric cancer. Br J Surg (1996) 1.21
Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation (2002) 1.21
Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial. J Clin Oncol (1992) 1.19
Combined intensive chemotherapy and radical surgery for incurable gastric cancer. Ann Surg Oncol (1997) 1.15
Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study. Surgery (1998) 1.11
Adjuvant and neoadjuvant therapy for gastric cancer. Semin Oncol (1996) 1.07
Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J Clin Oncol (1994) 1.06
Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up. Cancer (2001) 1.03
Early results of extended total gastrectomy for cancer. Cancer (1957) 1.03
Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-time RT-PCR. Br J Cancer (2004) 1.02
Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer. Ann Oncol (2001) 1.01
Quantitative detection of micrometastases in the lymph nodes of gastric cancer patients with real-time RT-PCR: a comparative study with immunohistochemistry. Int J Cancer (2003) 1.00
Improvement in treatment results of gastric cancer with surgery and chemotherapy: experience of 9,700 cases in the Cancer Institute Hospital, Tokyo. Semin Surg Oncol (1992) 0.96
Chemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Cancer Sci (2003) 0.95
Surgery for gastric cancer: the American view. Semin Oncol (1996) 0.95
Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. Am J Surg (2004) 0.93
Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program. J Clin Oncol (1992) 0.93
Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma--a population-based study in Sweden. Br J Cancer (2000) 0.88
Paclitaxel and concurrent radiation for gastric cancer. Int J Radiat Oncol Biol Phys (2000) 0.87
The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma. J Am Coll Surg (1995) 0.86
Quantitative molecular diagnosis of peritoneal lavage fluid for prediction of peritoneal recurrence in gastric cancer. Int J Oncol (2003) 0.85
Total gastrectomy with extended lymphadenectomy for "curable" stomach cancer: experience in a non-Japanese Asian center. J Am Coll Surg (1999) 0.84
Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives. Cancer Chemother Pharmacol (2004) 0.84
Extended (D2) lymphadenectomy in gastric cancer: a five year experience. Int Surg (2001) 0.82
Cancer chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant cancer chemotherapy for stages III/IV gastric cancers without peritoneal dissemination. Anticancer Res (2003) 0.82
Future strategies and adjuvant treatment of gastric cancer. Ann Oncol (2003) 0.79
Molecular method to quantitatively detect micrometastases and its clinical significance in gastrointestinal malignancies. Adv Clin Chem (2004) 0.79
Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice. Int J Oncol (2005) 0.77
Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM). Am J Clin Oncol (1999) 0.76
Perioperative adjunctive treatment in the management of operable gastric cancer. J Surg Oncol (2005) 0.76
Adjuvant chemotherapy of gastric cancer: which regimens? Ann Oncol (2005) 0.76
Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery (2013) 2.43
Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas (2004) 2.30
Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a critical reappraisal from the viewpoint of lymph node retrieval. J Am Coll Surg (2004) 2.18
Myocardial velocity gradient as a noninvasively determined index of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (2003) 2.05
Middle pancreatectomy: safety and long-term results. Surgery (2009) 1.69
Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis. Hepatology (2006) 1.61
Automated abdominal multi-organ segmentation with subject-specific atlas generation. IEEE Trans Med Imaging (2013) 1.55
Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. J Hepatol (2004) 1.55
Long term parathyroid function following total parathyroidectomy with autotransplantation in adult patients with MEN2A. Endocr J (2009) 1.54
Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. J Gastroenterol (2004) 1.52
Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas (2011) 1.52
Clinical significance of regulatory T-cell-related gene expression in peripheral blood after renal transplantation. Transplantation (2011) 1.47
Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin Cancer Res (2002) 1.46
Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat (2002) 1.45
Laparoscopic surgery for gastric cancer: a collective review with meta-analysis of randomized trials. J Am Coll Surg (2010) 1.42
Enzyme-linked immunosorbent assay for human leukocyte antigen antibody detection and urine protein test recommended for follow-up monitoring after renal transplantation. Transplantation (2008) 1.40
Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22. World J Surg (2011) 1.33
Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas (2012) 1.31
Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Ann Surg Oncol (2009) 1.27
Longterm outcomes of early-stage gastric carcinoma patients treated with laparoscopy-assisted surgery. J Am Coll Surg (2007) 1.26
Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis. Int J Oncol (2009) 1.25
Single-institute prospective trial of laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma. Gastric Cancer (2011) 1.22
PGP9.5 as a marker for invasive colorectal cancer. Clin Cancer Res (2002) 1.21
Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma: a review of 43 cases. J Am Coll Surg (2003) 1.21
Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma. Mol Carcinog (2011) 1.20
Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann Surg Oncol (2008) 1.19
Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo. Oncogene (2002) 1.19
A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric Cancer (CCOG0302 study). Anticancer Res (2007) 1.18
Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis. Clin Cancer Res (2003) 1.15
The potential of oncolytic virus therapy for pancreatic cancer. Cancer Gene Ther (2005) 1.13
A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703). Gastric Cancer (2010) 1.13
Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery? Pancreas (2009) 1.11
Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis. J Hepatol (2002) 1.09
Characterization of in vitro gutlike organ formed from mouse embryonic stem cells. Am J Physiol Cell Physiol (2004) 1.09
Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res (2002) 1.09
Negative pressure external drainage of the pancreatic duct in pancreaticoduodenectomy. Hepatogastroenterology (2010) 1.09
Preservation of the pyloric ring has little value in surgery for pancreatic head cancer: a comparative study comparing three surgical procedures. Ann Surg Oncol (2011) 1.08
Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation? Xenotransplantation (2004) 1.06
Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters. J Surg Oncol (2008) 1.06
Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Liver Int (2005) 1.06
Para-aortic lymph node metastasis in carcinoma of the head of the pancreas. Surgery (2005) 1.06
Amylase concentration of the drainage fluid as a risk factor for intra-abdominal abscess following gastrectomy for gastric cancer. World J Surg (2010) 1.04
Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2013) 1.04
Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol (2003) 1.01
Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival. Pancreas (2009) 1.01
Simultaneous Doppler measurement of portal venous peak velocity, hepatic arterial peak velocity, and splenic arterial pulsatility index for assessment of hepatic circulation. Hepatogastroenterology (2002) 1.01
Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines. Gastric Cancer (2014) 1.01
Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer. Gastric Cancer (2014) 1.00
Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen. Gastric Cancer (2005) 0.99
High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer. Breast Cancer (2006) 0.99
Metachronous double cancer of the gallbladder and common bile duct. J Hepatobiliary Pancreat Surg (2004) 0.99
Pattern of lymph node metastasis spread in pancreatic cancer. Pancreas (2011) 0.99
Construct validity of the LapVR virtual-reality surgical simulator. Surg Endosc (2010) 0.99
Hyperlactemia can predict the prognosis of liver resection. Shock (2007) 0.98
TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clin Exp Metastasis (2004) 0.97
Laparoscopic wedge resection for gastrointestinal stromal tumors of the stomach: initial experience. Surg Today (2006) 0.97
Prognostic significance of postoperative complications after hepatectomy for hepatocellular carcinoma. J Surg Oncol (2011) 0.97
Pilot study of oncolytic viral therapy using mutant herpes simplex virus (HF10) against recurrent metastatic breast cancer. Ann Surg Oncol (2006) 0.97
Decreased expression and aberrant hypermethylation of the SFRP genes in human gastric cancer. Hepatogastroenterology (2011) 0.97
Multicenter phase II study of FOLFOX for metastatic colorectal cancer (mCRC) in Japan; SWIFT-1 and 2 study. Hepatogastroenterology (2009) 0.97
Nutritional recovery after open and laparoscopic gastrectomies. Gastric Cancer (2011) 0.96
Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler. Cancer Lett (2002) 0.96
Differentiation of acinar cells into acinoductular cells in regenerating rat pancreas. Pancreatology (2003) 0.96
Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a phase II study following the learning curve. J Surg Oncol (2005) 0.96
Methylation pattern of HLTF gene in digestive tract cancers. Int J Cancer (2003) 0.96
Obesity and outcome of distal gastrectomy with D2 lymphadenectomy for carcinoma. Hepatogastroenterology (2004) 0.95
Plasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer. Cancer Sci (2006) 0.95
Chemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Cancer Sci (2003) 0.95
Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma. Jpn J Clin Oncol (2002) 0.95
Transhepatic portal venous angioplasty with stenting for bleeding jejunal varices. Hepatogastroenterology (2005) 0.94
Suppressor of cytokine signaling 4 detected as a novel gastric cancer suppressor gene using double combination array analysis. World J Surg (2012) 0.94
Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation. Xenotransplantation (2010) 0.93
Aggressive surgery for borderline resectable pancreatic cancer: evaluation of National Comprehensive Cancer Network guidelines. Pancreas (2013) 0.93
Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array. Cancer Lett (2009) 0.93